Stellar Biotechnologies Publishes New Corporate Profile
March 13, 2012 09:00 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Mar 13, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) announced today that the Company has published an...
Stellar Biotechnologies Announces Receipt of Lead Purchase Order
September 20, 2011 09:10 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Sep 20, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce they have received the first purchase order from...
Stellar Biotechnologies Awarded $498,560 Phase IIB National Science Foundation (NSF) Grant
August 29, 2011 16:05 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Aug 29, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that the National Science Foundation (NSF) has...
Stellar Biotechnologies Announces Pre-IDE Meeting With FDA
May 10, 2011 09:45 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - May 10, 2011) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) announces the completion of a pre-Investigational Device Exemption (pre-IDE) meeting...
Stellar Biotechnologies Appoints Vice President, Business Development & Marketing
March 08, 2011 08:55 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - March 8, 2011) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) has appointed Michael R. McClurg to VP, Business Development & Marketing. His...